334 related articles for article (PubMed ID: 22834409)
1. Polymer-based oral peptide nanomedicines.
Herrero EP; Alonso MJ; Csaba N
Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in protein and peptide drug delivery systems.
Malik DK; Baboota S; Ahuja A; Hasan S; Ali J
Curr Drug Deliv; 2007 Apr; 4(2):141-51. PubMed ID: 17456033
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
4. Design of nanoparticles composed of graft copolymers for oral peptide delivery.
Sakuma S; Hayashi M; Akashi M
Adv Drug Deliv Rev; 2001 Mar; 47(1):21-37. PubMed ID: 11251243
[TBL] [Abstract][Full Text] [Related]
5. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
Slomkowski S; Gosecki M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
[TBL] [Abstract][Full Text] [Related]
6. Review: Nanopreparations for better drug delivery.
Qadir MI
Pak J Pharm Sci; 2017 Nov; 30(6):2301-2309. PubMed ID: 29175803
[TBL] [Abstract][Full Text] [Related]
7. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
12. Role of nanotechnology in pharmaceutical product development.
Devalapally H; Chakilam A; Amiji MM
J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.
Gagliardi M; Bardi G; Bifone A
Ther Deliv; 2012 Jul; 3(7):875-87. PubMed ID: 22900468
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
15. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
Mohamed S; Parayath NN; Taurin S; Greish K
Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
[TBL] [Abstract][Full Text] [Related]
16. Polymeric core-shell nanoparticles for therapeutics.
Yang YY; Wang Y; Powell R; Chan P
Clin Exp Pharmacol Physiol; 2006; 33(5-6):557-62. PubMed ID: 16700894
[TBL] [Abstract][Full Text] [Related]
17. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.
Leyva-Gómez G; Cortés H; Magaña JJ; Leyva-García N; Quintanar-Guerrero D; Florán B
Drug Discov Today; 2015 Jul; 20(7):824-37. PubMed ID: 25701281
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines for delivery of therapeutic proteins and biopharmaceuticals.
Sarmento B
Ther Deliv; 2010 Aug; 1(2):231-5. PubMed ID: 22816130
[TBL] [Abstract][Full Text] [Related]
20. Challenges and new strategies for therapeutic peptide delivery to the CNS.
McGowan JW; Bidwell GL; Vig PJ
Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]